Yanhong Zhang, Zhenyang Liang, Shuai Wang, Renzhong Qiao, Chao Li
{"title":"Cross-subclass metallo-β-lactamase inhibitors: From structural and catalytic commonalities guiding design","authors":"Yanhong Zhang, Zhenyang Liang, Shuai Wang, Renzhong Qiao, Chao Li","doi":"10.1016/j.ejmech.2025.117479","DOIUrl":null,"url":null,"abstract":"<div><div>The emergence of antibiotic resistance mediated by metallo-β-lactamases (MβLs) has become a problem due to its diverse and widespread resistance characteristics. Research on broad-spectrum inhibitors has become an important issue. This review summarized the reported metallo-β-lactamases inhibitors (MβLIs) with cross-class activity, as well as four practical design strategies for developing cross-subclass MβLIs. It provides a detailed analysis of current inhibitors, covering their chemical structures, mechanisms, and cross-class activities. Four design strategies are discussed: i) substrate simulation strategy, ii) combining metal-chelating motifs strategy, iii) covalent inhibition strategy, and iv) metal ion replacement strategy. These strategies offer insights into developing effective cross-subclass MβLIs to combat the increasing prevalence of resistant pathogens.</div></div>","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"289 ","pages":"Article 117479"},"PeriodicalIF":6.0000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0223523425002442","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
The emergence of antibiotic resistance mediated by metallo-β-lactamases (MβLs) has become a problem due to its diverse and widespread resistance characteristics. Research on broad-spectrum inhibitors has become an important issue. This review summarized the reported metallo-β-lactamases inhibitors (MβLIs) with cross-class activity, as well as four practical design strategies for developing cross-subclass MβLIs. It provides a detailed analysis of current inhibitors, covering their chemical structures, mechanisms, and cross-class activities. Four design strategies are discussed: i) substrate simulation strategy, ii) combining metal-chelating motifs strategy, iii) covalent inhibition strategy, and iv) metal ion replacement strategy. These strategies offer insights into developing effective cross-subclass MβLIs to combat the increasing prevalence of resistant pathogens.
期刊介绍:
The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers.
A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.